Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Talbot A, Bobin A, Tabone L, Lambert J, Boccaccio C, Deal C, Petillon MO, Allangba O, Agape P, Arnautou P, Belkhir R, Cailleres S, Chaoui D, Chrétien ML, Decaux O, Schulmann S, Frenzel L, Gastaud L, Huart A, Hulin C, Karlin L, Laribi K, Le Calloch R, Lenain P, Macro M, Manier S, Montes L, Moreau S, Moreau P, Morel V, Norwood J, Piocelle FO, Perrot A, Pica GM, Rey P, Schmitt A, Stoppa AM, Tiab M, Touzeau C, Vidal V, Vignon M, Vincent L, Van De Wyngaert Z, Zarnitsky C, Kerbouche N, Paka P, Leleu X, Arnulf B, Avet-Loiseau H, Du Myélome IIF. Talbot A, et al. Among authors: belkhir r. Haematologica. 2023 Oct 1;108(10):2774-2782. doi: 10.3324/haematol.2022.281772. Haematologica. 2023. PMID: 37078253 Free PMC article.
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.
de Frémont GM, Costedoat-Chalumeau N, Lazaro E, Belkhir R, Guettrot-Imbert G, Morel N, Nocturne G, Molto A, Goulenok T, Diot E, Perard L, Ferreira-Maldent N, Le Besnerais M, Limal N, Martis N, Abisror N, Debouverie O, Richez C, Sobanski V, Maurier F, Sauvetre G, Levesque H, Timsit MA, Tieulié N, Orquevaux P, Bienvenu B, Mahevas M, Papo T, Lartigau-Roussin C, Chauvet E, Berthoux E, Sarrot-Reynauld F, Raffray L, Couderc M, Silva NM, Jourde-Chiche N, Belhomme N, Thomas T, Poindron V, Queyrel-Moranne V, Delforge J, Le Ray C, Pannier E, Mariette X, Le Guern V, Seror R; GR2 Study Group. de Frémont GM, et al. Among authors: belkhir r. Lancet Rheumatol. 2023 Jun;5(6):e330-e340. doi: 10.1016/S2665-9913(23)00099-1. Epub 2023 May 8. Lancet Rheumatol. 2023. PMID: 38251600
Efficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory disease.
Danion F, Rosine N, Belkhir R, Gottenberg JE, Hachulla E, Chatelus E, Pugnet G, Pers YM, Mariette X, Sibilia J, Seror R; Club Rhumatismes et Inflammation section of the French Society of Rheumatology. Danion F, et al. Among authors: belkhir r. Lupus. 2016 Nov;25(13):1440-1447. doi: 10.1177/0961203316640911. Epub 2016 Jul 11. Lupus. 2016. PMID: 27013663
Denosumab in active Charcot neuro-osteoarthropathy of the foot.
Carvès S, Bourgeon-Ghittori M, Henry J, Belkhir R, Besson FL, Levante S, Mariette X, Seror R. Carvès S, et al. Among authors: belkhir r. Joint Bone Spine. 2021 Dec;88(6):105241. doi: 10.1016/j.jbspin.2021.105241. Epub 2021 Jun 16. Joint Bone Spine. 2021. PMID: 34146697
Efficacy of daratumumab in refractory primary Sjögren disease.
Nocturne G, Marmontel O, di Filippo M, Chretien P, Krzysiek R, Lifermann F, Rahal N, Belkhir R, Moulin P, Mariette X. Nocturne G, et al. Among authors: belkhir r. RMD Open. 2023 Sep;9(3):e003464. doi: 10.1136/rmdopen-2023-003464. RMD Open. 2023. PMID: 37730313 Free PMC article. No abstract available.
54 results